TITLE 856 INDIANA BOARD OF PHARMACY

Temporarily amends 856 IAC 2-2-2 to add synthetic drug compounds to Schedule I. Statutory authority: IC 25-26-13-4.1. Effective 30 days after filing with the Publisher.

SECTION 1. (a) This SECTION is supplemental to 856 IAC 2-2-2.

(b) Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation, which contains any quantity of the following synthetic drugs, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subsection only, "isomer" includes the optical, position and geometric isomers):

Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) (Other names – Etilaam, Etizest, Depas, Etizola, Sedekopan, Pasaden)

DIN: 20161214-IR-856160535ERA

Composed: Apr 18,2024 2:10:01PM EDT

A PDF version of this document.